Document Detail


Novel ultrasound and DCE-MRI analyses after antiangiogenic treatment with a selective VEGF receptor inhibitor.
MedLine Citation:
PMID:  21531499     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We report a comparison between tumor perfusion estimates acquired using contrast-enhanced MRI and motion-corrected contrast-enhanced ultrasound before and after treatment with AG-028262, a potent vascular endothelial growth factor receptor tyrosine kinase inhibitor. Antiangiogenic activity was determined by assessing weekly ultrasound and MRI images of rats with bilateral hind flank mammary adenocarcinomas before and after treatment with AG-028262. Images were acquired with a spoiled gradient, 1.5 T magnetic resonance sequence and a destruction-replenishment ultrasound protocol. For ultrasound, a time to 80% contrast replenishment was calculated for each tumor voxel; for MR imaging, a measure of local flow rate was estimated from a linear fit of minimum to maximum intensities. AG-028262 significantly decreased tumor growth and increased the time required to replenish tumor voxels with an ultrasound contrast agent from 2.66 to 4.54 s and to fill with an MR contrast agent from 29.5 to 50.8 s. Measures of flow rate derived from MRI and ultrasound demonstrated a positive linear correlation of r2 = 0.86.
Authors:
Katherine D Watson; Xiaowen Hu; Chun-Yen Lai; Heather A Lindfors; Dana D Hu-Lowe; Theresa A Tuthill; David R Shalinsky; Katherine W Ferrara
Related Documents :
19881109 - Case report: magnetic resonance imaging in rabies encephalitis.
2392369 - Carbon monoxide poisoning: bilateral lesions in the thalamus on mr imaging of the brain.
21467249 - Rising use of ct in child visits to the emergency department in the united states, 1995...
9251079 - A tourette-like syndrome following cardiopulmonary bypass and hypothermia: mri volumetr...
6766039 - Ct in the early diagnosis of herpes simplex encephalitis.
9504479 - Hyperintense basal ganglia on t1-weighted mr images in a patient with central nervous s...
22334639 - Safety and efficacy of symptom-driven ct decision rule in fully conscious paediatric pa...
10764859 - Comparison of fluorescein angiography and indocyanine green angiography for imaging of ...
6609589 - The mediastinum in non-small cell lung cancer: ct-surgical correlation.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, N.I.H., Extramural     Date:  2011-04-30
Journal Detail:
Title:  Ultrasound in medicine & biology     Volume:  37     ISSN:  1879-291X     ISO Abbreviation:  Ultrasound Med Biol     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-05-23     Completed Date:  2011-11-18     Revised Date:  2012-04-11    
Medline Journal Info:
Nlm Unique ID:  0410553     Medline TA:  Ultrasound Med Biol     Country:  England    
Other Details:
Languages:  eng     Pagination:  909-21     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 World Federation for Ultrasound in Medicine & Biology. Published by Elsevier Inc. All rights reserved.
Affiliation:
Department of Biomedical Engineering, University of California, Davis, CA 95327, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenocarcinoma / complications,  diagnosis,  drug therapy
Angiogenesis Inhibitors / administration & dosage*
Animals
Cell Line, Tumor
Diffusion Magnetic Resonance Imaging / methods*
Female
Male
Mammary Neoplasms, Experimental / complications,  diagnosis*,  drug therapy*
Neovascularization, Pathologic / diagnosis*,  drug therapy*,  etiology
Rats
Rats, Inbred F344
Receptors, Vascular Endothelial Growth Factor / drug effects
Treatment Outcome
Ultrasonography / methods*
Grant Support
ID/Acronym/Agency:
P30CA093373-06/CA/NCI NIH HHS; R01 CA103828-06A1/CA/NCI NIH HHS; R01 CA103828-09/CA/NCI NIH HHS; R01 CA112356-07/CA/NCI NIH HHS; R01 CA134659-02/CA/NCI NIH HHS; R01 CA134659-04/CA/NCI NIH HHS; R01CA103838/CA/NCI NIH HHS; R01CA134659/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Angiogenesis Inhibitors; EC 2.7.10.1/Receptors, Vascular Endothelial Growth Factor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Characterizing the Subharmonic Response of Phospholipid-Coated Microbubbles for Carotid Imaging.
Next Document:  Diagnostic Value of Contrast-Enhanced Ultrasound, Computed Tomography and Magnetic Resonance Imaging...